How do people handle specimens from patients with suspected TSEs such as
CJD or vCJD? My feeling is that the universal precautions are the most
appropriate approach, but there is the problem that the infectious agents
are probably not sensitive to the usual methods of decontamination. Also,
if there are official procedures or guidelines we have to comply with them
even if they don't seem very rational, in this age of legislation and
litigation.
Maybe our UK contributors have thought this one through and have a specific
policy for avoidance of laboratory-acquired prion diseases?
John Whitfield
Clinical Biochemistry
Royal Prince Alfred Hospital
Sydney, Australia
Phone (+61) 2 9515 5246
Fax (+61) 2 9515 7931
Disclaimer:
This message is intended for the named addressee and may contain
confidential information.
If you are not the intended recipient, please disregard it.
Views are those of the sender and not necessarily those of Royal Prince
Alfred Hospital.
|